At a glance
ClinicalIndex Comparison RecordN/ACompleted· 15 enrolled
Drug / intervention
EyeControl devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety and Feasibility of the EyeControl Device (Eye-based Communication Device) for ALS Patients
In Brief
A clinical study evaluating EyeControl device for ALS (Amyotrophic Lateral Sclerosis). Completed, enrolled 15 participants.
Detailed Summary
The EyeControl device is an eye movement-based communication device in the form of wearable glasses with connected infrared cam-era that tracks the pupil and translates blinks and movements into commands.This study is aimed to demonstrate the safety and feasibility of the EyeControl device in healthy volunteers, and ALS patients in early stages.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsALS (Amyotrophic Lateral Sclerosis)
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartSep 2016
First PostedSep 2016
Primary CompletionJan 2017
Study CompletionFeb 2017
TodayJul 2026
First PostedSep 7, 2016
Enrollment StartSep 1, 2016
Primary CompletionJan 28, 2017
Study CompletionFeb 28, 2017
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 9.8 years ago
Interventions
EyeControl devicedevice
Use of device features including control of gestures, use of menus, activation of pre- defined modes and writing full sentences